Navigation Links
Dr Reddy’s Strikes Deal With Rheoscience For Type 2 Diabetes Dru

Dr Reddy's Laboratories Thursday announced it had entered a co-development and commercialisation agreement with Denmark-based Rheoscience A/S for the joint development of a drug to treat diabetes. //

Under the pact, Rheoscience will fund all costs associated with the Phase-III clinical trials of balaglitazone (DRF 2593), a partial PPAR-gamma agonist, for the treatment of type 2 diabetes.

Dr Reddy's will pay Rheoscience a pre-determined amount towards its share of development costs. According to a statement from Dr Reddy's, Rheoscience will retain marketing rights for the European Union and China while Dr Reddy's will retain marketing rights for the US and the rest of the world.

"We are excited about our first co-development deal for the joint development and commercialisation of balaglitazone. This deal provides Dr Reddy's with an opportunity to commercialise NCEs in key markets thereby transforming Dr Reddy's into an innovation driven business," said G.V. Prasad, CEO of Dr Reddy's Laboratories.

"This deal together with the announcement of Perlecan (Wednesday) reflects our commitment to accelerate the discovery efforts as well as clinical development programmes toward realising our vision of becoming a discovery-led global pharmaceutical company," he said.

The deal with Rheoscience came a day after Dr Reddy's announced the formation of India's first integrated drug development company - Perlecan Pharma Private Limited - with equity capital commitment of $52.5 million from India's leading venture capital investors, Citigroup Venture Capital International Growth Partnership Mauritius Limited and ICICI Venture Funds Management Company and Dr Reddy's.

Perlecan Pharma will be engaged in clinical development and out-licensing of new chemical entity (NCE) assets. Its early priorities will be to advance the clinical development of NCE assets received from Dr Reddy's and thereafter seek out-licensing , co-development or joint commercialisation opportunities.

-IANS
'"/>




Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Dr Reddy’s Laboratories launches Hyalosy
3. Polio Strikes Again
4. Chikungunya Strikes Chennai, India
5. New Research Suggests That Obesity Strikes Faster Growing Kids
6. Research for Back Pain Relief Strikes Gold
7. Polio Strikes Again in Delhi
8. Government Strikes Right Balance with PBS Reform
9. Stroke Due to Inherited Reasons Strikes Women More
10. Super Bug Strikes Again, Many Deaths Reported
11. Carriers With Alzheimers High Risk Gene Type Age Normally Until the Disease Strikes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Ky. (PRWEB) , ... October 13, 2017 , ... The ... MPH to become its next President and Chief Executive Officer, succeeding Dr. James C. ... CEO Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... PARK, Calif. , Oct. 11, 2017  BioPharmX ... national scientific team that developed an innovative way to ... quantity of the delivery of new drugs. ... 2017 Fall Clinical Dermatology Conference will show how researchers ... General Hospital, Harvard Medical School used a suite of ...
(Date:10/11/2017)... , Oct. 11, 2017  Hill-Rom Holdings, Inc. ... Aspen Surgical facility in Las Piedras, Puerto ... scalpels and blades. ... that the facility sustained minor structural damage, temporary loss ... Maria. Repairs have been completed, manufacturing operations have resumed, ...
(Date:10/7/2017)... 6, 2017   Provista, a proven leader ... billion in purchasing power, today announced a new resource ... The Newsroom is the online home for case ... expert bios, news releases, slideshows and events. ... wealth of resources at their fingertips, viewers can also ...
Breaking Medicine Technology: